TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: sustained improvements in OAB symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased muscle thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased hiatal area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: elevated position of the bladder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thyroid dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Satisfaction with abortion procedure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in fundus autofluorescence (AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean absolute slope of Vmca
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Development of AMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Vesikari scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 24-week disease control rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knowledge of oral cancer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: confidence to perform self-examination
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: anticipated delay
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Health-related job loss (HRJL)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: High level of health anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduced anticoagulation during CPB (PTT, ACT, TT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Increase of factor XII levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in inflammatory parameters (TNF-alpha, IL-6, IL-8, IL-10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroreversion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Segmental kyphotic angle restoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain and disability improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Gaining abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Child's outcome
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anticipatory speech state anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social anxiety symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: D-lactic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: verbal fluency task performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of ECMO
Endpoint domain: Mortality/survival
Primary endpoint: Combined incidence of death and ECMO
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increase in perceived well-being
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in depression levels
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functional Ambulation Classification (FAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak torque on the unaffected side
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CT dose index (CTDIw)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose-length product (DLP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active phase duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxytocin units administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent meatal stenosis
Endpoint domain: Adverse events/effects
Primary endpoint: coronary events
Endpoint domain: Mortality/survival
Primary endpoint: Histamine sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival and success rate of implants
Endpoint domain: Mortality/survival
Primary endpoint: Vertical bone loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: Reduction in angiogenesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time performance in surgical task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Local Recurrence-Free Survival (LRFS)
Endpoint domain: Mortality/survival
Primary endpoint: Increase in 25-OHD serum concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Migraine headache days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: mean total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: infection rates in infants
Endpoint domain: Adverse events/effects
Primary endpoint: plaque control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gingival indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: wear index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma beta2m levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived discrimination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: contact participation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: social acceptance
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: six-year survivorship with re-operation for any reason
Endpoint domain: Mortality/survival
Primary endpoint: mean pre-operative Harris Hip Score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total direct costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: sustained headache response for 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain-free rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of shoulder problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Prevalence of substantial shoulder problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: coagulopathy assessment and management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urological injury assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bowel injury/open fracture assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of major and nonmajor in-hospital bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of hematomas
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of catheter colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: PRO 2000 concentrations in CVL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV inhibitory concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low cardiac output syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Net fluid balance at 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine output at 0-24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: spontaneous rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intertapping interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: movement rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in ISGA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Probing Depth (PD) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Clinical Attachment Level (CAL) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ulcer resolution rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intentions toward preventive surgery
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Plasma cotinine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of alcohol assessment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of intervention (advised to cut back or offered treatment)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Androstenedione and testosterone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cost saving per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Societal cost saving
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Recruitment Index
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Attentiveness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Risk of death or AMI
Endpoint domain: Mortality/survival
Primary endpoint: plasma removal rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: platelet loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Effectiveness of venlafaxine-quetiapine vs. venlafaxine monotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Readiness to start antidementia drug treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Expectation of therapeutic impact
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum torque in isometric knee extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak power during maximal cycle performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lung function (FEV1 and FVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Optimal ART adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Catheter indwelling time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amount of apically extruded debris
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preparation-related moderate-to-severe abdominal pain
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in clinical findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective general assessment improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fist closure strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positivity rate of GTN-HUT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of GTN-HUT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bronchodilator efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Bone mineral density in vertebrae
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone mineral density in femora
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of osteomalacia
Endpoint domain: Adverse events/effects
Primary endpoint: total incidence of postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Best overall tumor response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Response and remission rates in treatment-resistant MDD patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: large arterial compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Variability of absorption of almotriptan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentrations of almotriptan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of recurrent angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: rate of revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in covering skin redness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in feelings of dryness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Virus elimination and/or virus load reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life (Minnesota Heart Failure score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: number of subjects with first falls
Endpoint domain: Mortality/survival
Primary endpoint: Satisfaction with paid care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-reported food craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: washout curve duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total corneal staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper-body strength as measured by biceps curl
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower-body strength as measured by chair sit-to-stand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac afterload
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Progesterone (P4) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: 30-day stroke incidence
Endpoint domain: Mortality/survival
Primary endpoint: 30-day death incidence
Endpoint domain: Mortality/survival
Primary endpoint: Progression-free survival (PFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: self-reported diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: number of criminal referrals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of days in locked settings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: levels of delinquent behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-ocular pressure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in serum AAT concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality-adjusted life years gained
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: decrease in radiation exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shoulder lowering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective image quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACR20 responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month maintenance of restored SR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Febrile neutropenia
Endpoint domain: Adverse events/effects
Primary endpoint: complete clearance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recording of seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced anesthesia risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intent to use condoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lung area under CPAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Tolerance of CPAP
Endpoint domain: Adverse events/effects
Primary endpoint: RSE incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Fracture healing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excellent and good rates according to Dienst wrist rating system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum cotinine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of small bowel injuries
Endpoint domain: Adverse events/effects
Primary endpoint: number of mucosal injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Decreased CBF in specific brain regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Olfaction scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hand motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arthrodesis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Willingness to enroll children in drug trials
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of health care services
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Frequency of disease occurrences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Insulin AUC0-180 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: sleep quantity
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: subjective evaluation of general sleep patterns
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: degree of sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Number of all-cause hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Anxiety reduction from baseline to 90 days
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Risk of incident atrial fibrillation (AF)
Endpoint domain: Mortality/survival
Primary endpoint: Presence of microorganisms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: P2Y12 reaction units 1 hour after the LD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of surgical site infections (SSIs)
Endpoint domain: Adverse events/effects
Primary endpoint: time to treatment intervention for depression
Endpoint domain: Mortality/survival
Primary endpoint: Urgent revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Visual Analogue Scale rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of painful joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Increase in QF muscle size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the gain of spinal transmission of nociceptive signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Recurrence-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Stroop Color‐Word Test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pregnancy success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Gross motor skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10K time improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: substance P concentration in tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ocular and nasal symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alcohol self-administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alcohol approach tendency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes